"AMIN News" American International Industries, Inc. Announces the Sale of 8 Acres in Houston, Texas by Its Wholly-Owned Subsidiary, Nestle Products Corporation, and Entering Into a Contract to Sell an Additional 34 Acres

http://money.cnn.com/news/newsfeeds/articles/globenewswire/187885.htm

Globe Newswire
April 01, 2010: 07:00 AM ET

HOUSTON and KEMAH, Texas, April 1, 2010 (GLOBE NEWSWIRE) -- Mr. Daniel Dror, Chairman and CEO of American International Industries, Inc. (Nasdaq:AMIN), today announced the completion of the sale of 8 acres of land located on Airport Boulevard in Houston, Texas by its wholly-owned subsidiary, Nestle Products Corporation (Nestle), for $450,000 cash. Mr. Dror further announced that a contract has been entered into by and between Nestle and Continental Connections USA, LLC to sell the additional 34 acres on Airport Boulevard for $1,550,000 cash. The total of 42 acres owned by Nestle and another 36 acre property on Interstate 59 in Houston, Texas are carried on AMIN's books at a $3.2 million cost to the company, which is net of a note payable to the bank.

American International Industries, Inc. is a diversified holding company, with a business model similar to General Electric, Tyco International, and Berkshire Hathaway. The Company has holdings in Industry, Finance, and Real Estate in Houston Texas and surrounding areas, and Oil & Gas. The vision of the Company is to develop holdings in various industries through acquisition of existing companies, applying the financial resources and management expertise to foster the growth and profitability of the acquired businesses. The holding company serves as a financial and professional partner to the management of the subsidiaries. The role of the holding company is to improve each subsidiary's access to capital, achieve economies of scale by consolidating administrative functions, and utilize the financial and management expertise of corporate personnel across all units. The Company is continuing to work with management of the subsidiary companies to improve revenues, operations and profitability.

"SOPW News" Solar Power, Inc. Contracted for Solar Solution at San Sevaine Villas Affordable Housing Complex
Solar System on Parking Shade Structures Will Deliver Energy and Cost Savings to Development

http://www.marketwatch.com/story/solar-power-inc-contracted-for-solar-solution-at-san-sevaine-villas-affordable-housing-complex-2010-04-01?reflink=MW_news_stmp

ROSEVILLE, Calif., Apr 01, 2010 (BUSINESS WIRE) -- Solar Power, Inc. ("SPI") /quotes/comstock/11k!sopw (SOPW 0.97, +0.02, +2.11%) announced today that the Company entered into a sub-contract agreement to install a 230 kW DC photovoltaic solar system at San Sevaine Villas, an affordable housing development located in Rancho Cucamonga, California. The system will provide approximately 374,770 kWh of electricity production annually, offsetting a significant portion of the complex's common area electricity costs, including two of the complex's biggest electricity consumers, its large community center and its laundry rooms. The solar system will allow the complex to significantly reduce energy costs, delivering an estimated $52,000 in annual electricity cost savings.

A leader in providing solar systems to affordable housing developments, Solar Power, Inc. has designed and installed systems for other major affordable housing developers including Community HousingWorks' award winning Solara development in Poway, California. Other developers utilizing Solar Power, Inc.'s system solutions include Interfaith Housing, Wakeland Housing, MacFarlane Costa, BRIDGE Housing, and The Monterey County Housing Authority. The Company was engaged by Wermers Companies, the general contractor for the San Sevaine Villas project, to design and build the solar system incorporated into the complex's parking shade structure. The two companies have worked together successfully on affordable housing developments in the past.

"We have a successful history of producing solar systems for the affordable housing industry," said Bradley Ferrell, President of Business Development for Solar Power, Inc. "We look forward to working with the team at Wermers Companies again to help the project owner, Northtown Housing Corporation, deliver a low-cost energy solution to its residents."

"AGT News" Apollo Gold and Linear Gold Enter into Definitive Arrangement Agreement

http://www.marketwatch.com/story/apollo-gold-and-linear-gold-enter-into-definitive-arrangement-agreement-2010-04-01?reflink=MW_news_stmp

DENVER & HALIFAX, Nova Scotia, Apr 01, 2010 (BUSINESS WIRE) -- Apollo Gold Corporation /quotes/comstock/11t!apg (CA:APG 0.35, -0.01, -2.78%) /quotes/comstock/14*!agt/quotes/nls/agt (AGT 0.34, -0.01, -3.57%) ("Apollo") and Linear Gold Corp. /quotes/comstock/11t!lrr (CA:LRR 1.72, +0.02, +1.18%) ("Linear") are pleased to announce today that they have entered into a definitive arrangement agreement (the "Arrangement Agreement") in respect of the previously announced business combination (the "Merger") pursuant to which the businesses of Apollo and Linear will be combined by way of a court approved plan of arrangement. The Arrangement Agreement supercedes the letter of intent executed by Apollo and Linear on March 9, 2010 in respect of the Merger.

Wade Dawe, Chief Executive Officer ("CEO") and President of Linear, who will be appointed as CEO and President of the combined company, said, "The signing of the Arrangement Agreement is another step towards closing of the Merger which will create an emerging Canadian mid-tier gold producer. Our new company will be well positioned as the new gold investment vehicle of choice for investors seeking growing gold production in Canada, increasing gold mineral resources, a financially strong balance sheet and a superior pipeline of projects in politically stable jurisdictions."

R. David Russell, CEO and President of Apollo, added, "Both Apollo and Linear are working together to complete the Merger as well as prepare for a smooth transition to start a new chapter for the combined company in 2010. This year also marks the first full year of production from the Black Fox Mine in the Timmins Mining District, including the start of production from the new underground mine in the second half of 2010."

The consummation of the Merger as contemplated by the Arrangement Agreement is subject to a number of conditions precedent, including approval of the shareholders of each of Apollo and Linear. The parties currently anticipate that the Merger will be completed in June 2010. It is expected that proxy and management information circulars will be mailed to respective Apollo and Linear shareholders in May 2010.

"PBTH News" PROLOR Biotech Awarded Second Israeli Government Grant to Support Development of its Longer-Acting Interferon Beta

http://www.prnewswire.com/news-releases/prolor-biotech-awarded-second-israeli-government-grant-to-support-development-of-its-longer-acting-interferon-beta-89676117.html

-- Interferon-Beta-CTP Development Program Has Been Approved For Second Year Funding Through a Special Grant from the Israeli Office of the Chief Scientist --

NES-ZIONA, Israel, April 1 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH), a company developing next generation biobetter therapeutic proteins, today announced that the Israeli Office of the Chief Scientist ("OCS") has approved a 2010 continuation of its grant to PROLOR's Israeli-based R&D subsidiary for the company's development program for interferon-beta-1a-CTP (IFN-Beta-CTP), its longer-acting version of interferon-beta-1a (IFN-Beta). IFN-Beta, which is indicated for the treatment of multiple sclerosis (MS), is currently marketed by Merck Serono as Rebif® and by Biogen Idec as Avonex®, with combined 2009 annual sales estimated at more than $4.4 billion worldwide.

PROLOR recently reported positive results from a study in primates comparing PROLOR's CTP-modified IFN-Beta with commercially available IFN-Beta. The study showed that in primates, PROLOR's CTP-modified IFN-Beta had 13 times greater durability (half-life) and 55 times greater overall drug exposure (AUC) compared to commercially available IFN-Beta. IFN-Beta-CTP also demonstrated strong biological potency as measured by several well-validated biomarkers.

Based on the results of the comparative study, the OCS approved a special continuation grant to support PROLOR's IFN-Beta-CTP program for 2010. The grant is expected to provide cash reimbursements for approximately 35% of the estimated $1.5 million in expenses expected to be paid for IFN-Beta-CTP product development during 2010.

"This generous continuation grant from the OCS is an important non-dilutive cash resource for PROLOR's IFN-Beta-CTP development program, and we believe that it represents another validation of the potential of our CTP technology," said Abraham Havron, Ph.D., Chief Executive Officer of PROLOR. "Going forward, we also hope to obtain an average of 35% cash reimbursements from the OCS for our IFN-Beta-CTP development expenses in 2011 and 2012. This visionary program is particularly attractive for PROLOR because the grants are repaid only upon the generation of commercial revenue from IFN-Beta-CTP or our other CTP-based products. We are grateful for this valuable source of non-dilutive capital."

Under the terms of the grant, PROLOR is required to repay the OCS the sum of the grant plus accrued interest through a series of payments that would begin only when the IFN-Beta-CTP product or other products that PROLOR develops with its CTP technology begin to generate commercial revenues.

"Exnt News" EnXnet, Inc. Receives Patent for The ThinDisc Technology

http://www.marketwatch.com/story/enxnet-inc-receives-patent-for-the-thindisc-technology-2010-03-31?reflink=MW_news_stmp

TULSA, Okla., Mar 31, 2010 (BUSINESS WIRE) -- EnXnet, Inc., /quotes/comstock/11k!exnt (EXNT 0.07, +0.02, +40.28%) (German WKN# A0HMDW) is pleased to announce that it has received the official Patent for the Optical Disc Having A Reduced Planar Thickness, or we refer to it as the ThinDisc. This is a very important patent for the Company.

EXNT has several other patent filings that are very close to completion.

Ryan Corley, CEO of EnXnet, Inc., stated, "It has been a very long road to get here. It has been the shareholders' wish, as well as mine, that we would be much further along than we currently are. We are now in a more powerful position than before."

"BMGI News" Big Star Media Group Announces Distribution Deal with Brody Distribution Group and Sony/RED
Copyright 2010 PR Newswire. All Rights Reserved
2010-03-31

http://www.itnewsonline.com/showprnstory.php?storyid=95668

CLARKSDALE, Miss., March 31 /PRNewswire-FirstCall/ -- Big Star Media Group, Inc.
(Pink Sheets: BMGI) (the "Company"), a diversified entertainment and information
distribution company, today announced that the Company has reached an agreement
in principle with the Brody Distribution Group ("BDG") for subdistribution of
its content through the Sony/RED Distribution LLC ("RED").

The multi-year deal provides for the exclusive distribution of its content
throughout North America for physical formats and worldwide for digital formats.
The Brody Distribution Group was formed by entertainment industry veterans Jeff
Brody and Michael Resnick, who, collectively, have decades of experience in the
retail sales and distribution of independent and major label content.
Additionally, BDG will provide select marketing and promotional services for the
Company.

BDG specializes in the marketing, sales, and distribution of music products.
Between them, their experience covers virtually every facet of the sales,
marketing, and distribution business in the entertainment industry. Over the
years, they have been collectively involved with notable artists and projects
such as The Village People, Gloria Gaynor, Kiss, Def Leppard, Bon Jovi, John
Mellencamp, Vanessa Williams, Hanson, Andrea Bocelli, 98 Degrees, Rusted Root,
Joan Osborne, Brian McKnight, Tony Toni Tone, Robert Cray, Los Lonely Boys, Led
Zeppelin, CSN&Y, Tori Amos, The Who, and Hootie & the Blowfish. Before Jeff
Brody established BDG in 1999, he was the senior vice president of Sales &
Retail Marketing for Mercury Records and their associated labels, which included
Def Jam and Capricorn. Prior to BDG, Michael Resnick worked with the Atlantic
Records Group, Elektra Entertainment Group, Arista, Stax, Epic, and CBS Records
(now SONY).

RED is a wholly owned division of Sony Music Entertainment that markets and
distributes releases for 50+ independent record labels. The National Association
of Recording Merchandisers (NARM) has named RED Distributor of the Year/ Medium
Division four out of the last five times it has voted.

Jeff Skillen, CEO of Big Star Media said, "We're excited to be in business with
both the Brody Distribution Group and Sony/RED. This deal provides us the
marketing and distribution muscle necessary to build a platform for the ongoing
sales and marketing of our content."

"The content and business plan of Big Star Media is a great fit for our
company," remarked Jeff Brody, CEO of BDG. "It's great for us to be working with
a team of seasoned executives with the skills and resources needed to be
competitive in today's marketplace."

"RED is very pleased to distribute artists from Big Star Media," said Bob
Morelli, president of RED Distribution. "Our staff is looking forward to
introducing their content into the marketplace and working with their team to
develop new opportunities."

"HYBE News" Hybrid Energy to Add $1,000,000 Revenue per Year From Production of 4.6 Billion Cubic Feet of Reserves

http://money.cnn.com/news/newsfeeds/articles/marketwire/0602495.htm

Marketwire
March 31, 2010: 08:30 AM ET

Hybrid Energy Holdings, Inc. (PINKSHEETS: HYBE) announced today its planned new production from one of its recently acquired energy properties. The Company's "Coates" property contains known reserves of 5 Billion Cubic Feet. Production is planned to commence from the 9,800 foot 'pay-zone' and is projected to add $1,000,000 per year in revenue.

The Company holds 9 energy production properties in its portfolio with 35 Billion Cubic Feet of verified reserves and maintains daily production from an estimated $30,000,000 in active reserves. The portfolio has an estimated $145,000,000 in available known reserves.

The Company will continue activating new production from its reserves and issue shareholder guidance accordingly.

"BFRE News" BlueFire Ethanol Files 2009 Form 10-K; Company Posts First Ever Profit

http://www.prnewswire.com/news-releases/bluefire-ethanol-files-2009-form-10-k-company-posts-first-ever-profit-89589827.html

IRVINE, Calif., March 31 /PRNewswire-FirstCall/ -- BlueFire Ethanol Fuels, Inc. (OTC Bulletin Board: BFRE), a company focused on changing the world's transportation fuel paradigm through the production of ethanol and other bio-fuels from non-food cellulosic wastes, has filed its Annual Report on Form 10-K for the fiscal year ended on December 31, 2009, with the US Securities and Exchange Commission (the "SEC"), posting 2009 revenue of $4,318,213 resulting in $0.04 profit per share.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090511/BLUEFIRELOGO)

"Through BlueFire's continued progress on developing its two planned cellulosic ethanol plants, BlueFire was able to recoup development costs previously expensed dating back to 2007. Late in 2008, BlueFire sought guidance from the SEC on the correct treatment of these reimbursements. It was determined that these reimbursements should be treated as revenue, as the costs were expensed in prior periods and expenses related to the grant are not directly identifiable due to the composition of the reimbursements. These reimbursements along with sugar sales and consulting fees resulted in a $0.04 per share profit," said Arnold Klann, Chief Executive Officer of BlueFire Ethanol.

In 2009, BlueFire began to develop relationships with key industry partners such as Solazyme, Inc., a renewable oil production company and leading algal synthetic biology company. Solazyme has been testing sugars produced through BlueFire's patented process, for compatibility with its renewable oil process to produce the bio-oil cost effectively and at scale. "The relationship with Solazyme, and others we are developing, will provide BlueFire the opportunity to be a full service fuel supplier to the ethanol, bio-diesel, bio-jet, and other drop-in fuel markets," said Arnold Klann.

Currently, BlueFire Ethanol is focused on the development of two cellulosic ethanol facilities in Lancaster, CA and Fulton, MS. The fully-permitted and shovel-ready Lancaster, CA facility, BlueFire's first U.S. commercial plant, will use post-sorted cellulosic wastes diverted from Southern California's landfills to produce approximately 3.9 million gallons of fuel-grade ethanol per year. BlueFire is in the detailed engineering phase for its second commercial plant in Fulton, MS, which will produce approximately 19 million gallons of ethanol per year from woody biomass, mill residue, and other cellulosic waste. The company expects to have all necessary permits for this second plant by summer 2010, putting the company on a path to commence construction by the end of 2010. These two planned facilities will create more than 1,000 construction jobs and, once in operation, more than 100 new operations and maintenance jobs. This is in addition to the hundreds of jobs created or maintained at equipment vendors and suppliers.

"As BlueFire progresses into construction, we see the bulk of future revenue and profits will result from owning and operating these facilities," added Klann.

About BlueFire Ethanol Fuels

BlueFire Ethanol Fuels, Inc. was established to deploy a commercially ready, patented and proven Concentrated Acid Hydrolysis Technology Process for the profitable conversion of cellulosic waste materials ("Green Waste") to ethanol, a viable alternative to gasoline. BlueFire is the only cellulose-to-ethanol company worldwide with demonstrated production of ethanol from urban trash (post-sorted MSW), rice and wheat straws, wood waste and other agricultural residues.

BlueFire is one of four companies awarded funding from the U.S. Department of Energy under the Energy Policy Act of 2005 to construct cellulosic biorefinery production facilities. BlueFire's biorefineries will be located near markets with high demand for ethanol and will use locally available biomass. This should dramatically reduce delivery costs and increase biofuel supplies, while providing a unique waste processing technology to help America's cities better manage the increasing problem of overflowing landfills. For more information, please visit www.BlueFireEthanol.com.

If you would like to receive regular updates on BlueFire Ethanol, please select this following link: http://www.b2i.us/irpass.asp?BzID=1437&to=ea&s=0.

"VIVK News" Vivakor Ships Product to Regeneca on Order of 25,000 Units

http://www.marketwatch.com/story/vivakor-ships-product-to-regeneca-on-order-of-25000-units-2010-03-31?reflink=MW_news_stmp

CORALVILLE, Iowa, Mar 31, 2010 (GlobeNewswire via COMTEX) -- Vivakor, Inc. /quotes/comstock/11k!vivk (VIVK 0.10, +0.01, +11.76%) today announced that it has shipped the first order of RegeneBlend(TM) to Regeneca International, Inc. (www.regeneca.com). The shipment on the 25,000 bottle order (retail value $1.5 million) represents the first installment under the $5 million license agreement that Vivakor and Regeneca entered into in November 2009. Under the terms of the license, Vivakor exclusively licensed to Regeneca, for the direct to consumer market, distribution rights to the new cutting-edge nutraceutical formulation developed by Vivakor. Regeneca has committed to purchase from Vivakor a minimum of $5 million in product over the initial three year license term and Vivakor received a 15% ownership interest in Regeneca's outstanding common stock and will be the exclusive supplier of the licensed product to Regeneca.

Vivakor CEO Dr. Tannin Fuja continues to express enthusiasm for the transaction, "This initial shipment is another step in Vivakor's development of a broad array of formulary products. We are extremely pleased to have partnered with our friends at Regeneca to market this amazing product."

Dr. Fuja continued, "We are particularly pleased to include in the formulation the powerful, marquis super-antioxidant yum berry (yang-mei in Chinese), also known as red bayberry, which is harvested from one hundred-year-old trees, and the flavonoid-rich concord grape, which has been shown to contain potent antioxidants that may protect against oxidative stress and reduce the risk of free radical damage and chronic diseases."

Regeneca's President, Larry Walter, echoed Dr. Fuja's sentiments, "For us at Regeneca, this represents a terrific step forward. We have taken so many pre-orders for this product; we have already begun the process of planning our next order."

"FDRM News" Distributor for Green-Waste Technologies Selected by Freedom Environmental Commercial and Residential Marketing of "Septi-Free" and "The Grease Separator"

http://www.marketwatch.com/story/distributor-for-green-waste-technologies-selected-by-freedom-environmental-2010-03-31?reflink=MW_news_stmp

ORLANDO, Fla., Mar 31, 2010 (GlobeNewswire via COMTEX) -- Freedom Environmental Services (Pink Sheets:FRDM) announced today that it has entered into a primary distribution agreement with Lone Star Green Distributors, LLC to cover the state of Texas. Lone Star will market Freedom's suite of environmentally safe products, including Freedom's proprietary "Septi-Free" and patented "The Grease Separator."

"There are so many different manufacturers of eco-friendly wastewater products today. The customer needs to be careful and make sure that what they are getting is truly eco-friendly, but more importantly, high quality," said R. Rainwater, President and CEO, Lone Star Green Distributors. Freedom offers both eco-friendly and high-quality products.

Management estimates that the global market for green technologies is estimated to grow to $700.00 billion by the end of 2010 on the back of demand for advanced and efficient distribution, collection, transfer, and treatment solutions. Numerous green technologies are being used for optimum water and wastewater treatment and promoting green and sustainable environment. This green movement includes optimum water and wastewater management among utilities and industries. Companies are increasingly resorting to green technologies to not only conserve resources but to also save costs, and we believe that Lone Star Green Distributors will serve these company goals.

Our management approximates that there are over 60,000 restaurants in the state of Texas and Lone Star Green Distributors will initially be focused on the DFW Metroplex and Houston, expecting product distribution to propagate from there. We surmise that Houston alone has over 9000 restaurants while Dallas/Fort Worth has over 7000. For the residential products, our management believes that Texas is ranked number 2 in the nation in adult residents behind California. Census figures show Texas at over 20M in adult residents. We presume that the penetration of the Texas market should have a very significant impact on the company's revenues.

Through Lone Star Green's distribution network, environmentally safe water treatment products will be made available for sale to commercial customers such as property managers and municipalities, plumbing contractors and building trades as well as residential customers. We believe that these distribution segments will help grow the sale of Freedom Environmental Services water treatment products to the American consumer located in the great state of Texas.

"Lone Star Green Distributors, LLC was chosen by Freedom Environmental Services as a distributor based on the company's well-respected leadership in the Dallas/Fort Worth Metroplex. They are well known for having a wide customer base, high standards of business integrity and superior levels of customer service," said Michael Borish, President and CEO of Freedom Environmental Services.

R. Rainwater, Lone Star Green Distributors, LLC owner, said, "We are honored to represent the Freedom Environmental Services (FES) product line and look forward to supplying FES products that so many of our customers have asked for. We are excited about this new venture and look forward to a long and successful relationship with the Freedom Environmental Services Team."

Mr. Rainwater formed Lone Star Green Distributors, LLC specifically for this distribution enterprise. His existing distribution channels directly correlate to the product line and will allow FES to immediately benefit from this agreement.

Mr. Rainwater is a well-established investor and entrepreneur in the Greater Dallas/Fort Worth Area.

"BLVI News" Black Art Beverage Announces New Contract

http://money.cnn.com/news/newsfeeds/articles/marketwire/0602710.htm

Premier German Beer Importer Adds 10 More States for Distribution
March 31, 2010: 08:00 AM ET

Black Art Beverage, Inc. (PINKSHEETS: BLVI) publicized today that it had completed negotiations with and signed an agreement for 10 more distribution states with Southern Italy Imports of Verona, Wisconsin. The agreement calls for Southern Italy to distribute the German Import Beer in the states of Wisconsin, southern Illinois, Indiana, Ohio, Kentucky, North Dakota, South Dakota, Minnesota, Missouri and Iowa.

Southern Italy Imports (http://www.southernitalyimports.com/tola_english.html) is a third generation importer and distributor in the upper mid-west and central regions of the United States.

"Including Southern Italy as a distribution partner gives our mid-west and central United States marketing effort an extra added push into bars, restaurants, grocery, c-stores and clubs. We really look forward to a great and prosperous future with them as a distribution partner," Mike Coffman, COO of Black Art Beverage, said.

For information on other Black Art Beer events please see our website http://www.blackartbeer.com or look for us on Facebook as Black Art Beer and become a friend of the brewery.

"SNVP News" Savoy Energy Corporation Secures Revenue Interest in an Estimated Recoverable Reserves of 27,000 Barrels of Oil Equivalent

http://money.cnn.com/news/newsfeeds/articles/globenewswire/187783.htm

Estimated Production Should Reach 50 Barrels of Oil Per Day
March 31, 2010: 07:00 AM ET

HOUSTON, March 31, 2010 (GLOBE NEWSWIRE) -- Savoy Energy Corporation (OTCBB:SNVP) an independent oil and gas company announces today it has secured working and revenue interest in a new well with Paragon Petroleum, Inc. of Houston, Texas. Based on geological reports, the recoverable reserves are estimated to be 27,000 barrels of oil equivalent when on-line and producing. The Company expects that this well will generate approximately 50 barrels of oil per day and 250 mcf of gas in initial production after removal of frac fluid.

The Glass 59 #2 well in Sterling County, Texas is operated by Bright & Company. The Glass 59 #2 well, which has been drilled to a depth of 6,500 feet, has one producing oil zone and one producing gas zone. This will be the fourteenth (14th) producing well that has been drilled within a 5000-acre prospect area and taps into what is known as the Wolfcamp formation. This prospect area is located in Sterling and Mitchell counties, Texas. Testing of the well is expected to be complete within the next three weeks.

This will be the fourth producing well that Savoy Energy has working and revenue interest in and is in definitive discussions with other operators that will increase the Company's total well interests. Currently Savoy Energy has nearly 53% working interests in three other producing wells in Gonzales County, Texas that is producing approximately 40 barrels of oil per day.

"We are excited to participate with Paragon Petroleum on this project and look forward to future participation on other projects," said Arthur Bertagnolli, CEO Savoy Energy Corporation.

"SOPW News" Solar Power, Inc. Applauds Signing of Senate Bill 205
SB 205 Helps School Districts Accelerate Solar Power Adoption Programs and Reduce Energy Costs Using Qualified School Construction Bonds

http://www.marketwatch.com/story/solar-power-inc-applauds-signing-of-senate-bill-205-2010-03-31?reflink=MW_news_stmp

ROSEVILLE, Calif., Mar 31, 2010 (BUSINESS WIRE) -- Solar Power, Inc. ("SPI") /quotes/comstock/11k!sopw (SOPW 0.95, -0.02, -2.06%) announced today that the March 25, 2010 signing of Senate Bill 205 by Governor Arnold Schwarzenegger helps clear the way for school districts across the state to leverage Qualified School Construction Bonds (QSCBS) to finance infrastructure projects, including the installation of solar systems to reduce energy costs. The bill provides municipalities the authority to move forward with selling these bonds to fund qualified projects. QSCBs are part of the $787 billion American Recovery and Reinvestment Act (ARRA) of 2009. The ARRA authorizes these special low-interest bonds for schools seeking to improve infrastructure. QSCBs provide federal tax credits for bondholders in lieu of interest in order to significantly reduce an issuer's cost of borrowing, providing a win-win solution for all parties.

Recently, Solar Power, Inc. announced that it will begin construction this summer of 2.24 megawatts of multiple systems across Baldwin Park Unified School District (BPUSD). The eight systems will be installed at seven schools and at the BPUSD district offices. BPUSD selected QSCBs as the optimal means of financing the solar systems for the district. In addition to BPUSD, Solar Power, Inc. has other school districts it is working with in its immediate pipeline, including Washington Unified School District (WUSD). The WUSD Board recently approved allocation of QSCB' to fund a 1.25 megawatt solar energy which Solar Power, Inc. co-developed with DRI Energy.

"We were happy to see the anticipated signing of SB 205 take place. As a financial instrument Qualified School Construction Bonds are a very effective way to help school districts make much needed improvements. They provide an opportunity to finance solar systems that will deliver energy cost savings for decades," said Jeff Winzeler, CFO of Solar Power, Inc.

"CIDM News" Cinedigm Announces Final Theatre Locations for the Live 3D Broadcast of the 2010 NCAA Men's Final Four(R) and Championship Games

http://www.marketwatch.com/story/media-alert-cinedigm-announces-final-theatre-locations-for-the-live-3d-broadcast-of-the-2010-ncaa-mens-final-fourr-and-championship-games-2010-03-30?reflink=MW_news_stmp

MORRISTOWN, NJ and LOS ANGELES, CA, Mar 30, 2010 (MARKETWIRE via COMTEX) -- On March 9, 2010, Cinedigm Digital Cinema Corp. /quotes/comstock/15*!cidm/quotes/nls/cidm (CIDM 1.74, -0.10, -5.43%) , the world leader in digital cinema and distributor of 3D events, announced in partnership with CBS Sports, the NCAA and LG Electronics USA, that the 2010 NCAA Men's Final Four and Championship games on Saturday, April 3rd and Monday, April 5th would be distributed in Live 3D to Cinedigm CineLive(TM) equipped theatres around the country. The first Semi-Final game between Butler and Michigan State starts at 6 pm eastern time, and the 2nd Semi-Final game between Duke and West Virginia starts at 8:45 pm eastern time. The Final game on Monday starts at 9 pm eastern time.

"VPCO News" Vapor Corp. Inks International Licensing Deal

http://money.cnn.com/news/newsfeeds/articles/marketwire/0602479.htm

March 30, 2010: 04:37 PM ET

Vapor Corp. (PINKSHEETS: VPCO) has entered into an international licensing agreement with Shenzhen First Union Technology Co, LTD. ("First Union") to market and distribute Vapor Corp. brands, Fifty-One and EZSmoker; First Union will distribute these brands worldwide, and Vapor Corp. will continue to distribute these brands in the United States. Vapor Corp. and First Union will join forces to launch this international license at the AsiaWorld Expo Electronics Show in Hong Kong, April 12-15, 2010 (www.chinesesourcingfair.com), and the Canton Fair in Guangzhou, April 15-19, 2010 (www.cantonfair.org.cn).

"This is a natural partnership, allowing us to promote and sell our brands to an international audience," says Kevin Frija, President and CEO of Vapor Corp."First Union is one of the largest and most reliable manufacturing facilities for the electronic cigarette industry. This partnership will allow First Union to take advantage of our branding and marketing expertise, and we will be able to take advantage of First Union's manufacturing and technical expertise. This partnership will allow for significant, worldwide exposure of our brands." In connection with the licensing agreement, and based on achieving certain milestones, First Union will be granted stock options in the Company. "First Union having a vested interest in our company is a huge benefit for our company and will make certain our interests are aligned," says Frija.

"SCLN News" SciClone Announces Topline Results From Phase 2 Clinical Trial of SCV-07 for Prevention of Oral Mucositis
Study Shows Signal of Delay to Onset of Severe OM in Higher Dose Group

http://www.marketwatch.com/story/sciclone-announces-topline-results-from-phase-2-clinical-trial-of-scv-07-for-prevention-of-oral-mucositis-2010-03-30?reflink=MW_news_stmp

FOSTER CITY, CA, Mar 30, 2010 (MARKETWIRE via COMTEX) -- SciClone Pharmaceuticals, Inc. /quotes/comstock/15*!scln/quotes/nls/scln (SCLN 3.71, -0.09, -2.37%) today announced topline results from the company's phase 2 clinical trial of SCV-07 for the prevention of severe oral mucositis (OM) (World Health Organization, WHO scale, grades 3 to 4) -- a painful, debilitating, and costly toxicity caused by chemoradiotherapy regimens used to treat head and neck cancer. This proof of concept study was intended to provide an estimate of SCV-07's treatment effect and guide further studies of SCV-07 in addressing this serious unmet medical need. Patients receiving the study's higher dose (0.1 mg/kg) of SCV-07 showed a trend towards delay to onset of severe OM, the study's primary endpoint. Patients in the low dose treatment arm (0.02 mg/kg) appeared to do worse than placebo, suggesting that the treatment effect is sensitive to dose. Additionally, SCV-07 was safe and well tolerated with no drug-related serious adverse events reported, indicating that there is potential to administer higher doses of SCV-07 in future clinical studies.

Additional data analysis showed a more pronounced clinical benefit for patients in the high dose treatment arm when evaluating the delay to onset of ulcerative OM (WHO scale, grades 2 to 4), an expanded measure of OM. In this analysis, the low dose treatment arm appeared similar or slightly better than placebo.

"We are encouraged that the trial provides an indication of a biological signal, in the high dose arm, for the pre-specified primary endpoint of the study," said Stephen T. Sonis, DMD, DMSc, Senior Physician, Brigham and Women's Hospital, Professor of Oral Medicine, Harvard School of Dental Medicine, and a leading expert in oral mucositis. "The finding that extends this signal to ulcerative OM is important, as ulceration is the major cause of the morbidity associated with OM."

Based on these study findings, SciClone intends to initiate discussions with the United States Food and Drug Administration regarding the design of a second phase 2 study of SCV-07 for the prevention of OM, which would involve higher doses. SciClone has also submitted a late-breaking abstract on results of this study for the 2010 American Society of Clinical Oncology Annual Meeting.

"We believe these findings support the concept that SCV-07 could provide a clinically meaningful benefit in the prevention of OM for patients with head and neck cancer being treated with chemoradiotherapy by stimulating the immune system through critical signaling pathways," said Israel Rios, MD., Chief Medical Officer and Senior Vice President of SciClone.

The phase 2 multicenter, randomized, double-blind, placebo-controlled, dose ranging proof of concept study was designed to assess the safety and tolerability of SCV-07 as well as provide an indication of efficacy in delaying the onset of severe OM, as assessed by the WHO scale, in patients receiving standard chemoradiation therapy for treatment of cancers of the head and neck. The study was not designed to demonstrate statistical significance and the results are not statistically significant. The study was conducted at 21 centers in the United States and included 59 patients. Patients received either placebo, SCV-07 at a dose of 0.02 mg/kg, or SCV-07 at the higher dose of 0.10 mg/kg. The treatment period was approximately seven weeks depending on the patient's prescribed radiation plan, with a follow-up visit approximately 30 days following the last day of radiation therapy.

About Oral Mucositis OM is a painful, debilitating and costly toxicity of many of the drug or radiation regimens used to treat cancer. OM is a condition in which the sensitive cells lining the mouth and throat are damaged by cancer treatments such as chemotherapy (with or without radiation) and become painful mouth sores. Severe OM has been reported to occur in about 50% of patients who receive chemoradiation for the prevention of cancers of head and neck (Sonis, Core Evidence, 2009). Importantly, radiation to the head and neck, especially when it includes the tissues of the mouth, pharynx and hypopharynx, results in significant ulcerative OM in greater than 90% of patients (Manas et al, Clinical Translational Oncology, 2009) and can compromise the patient's ability or willingness to accept a complete course of therapy. Symptoms can include painful ulcers in the mouth and throat, redness and swelling of the gums, dryness and overall soreness in the mouth, and difficulty eating, swallowing, talking and drinking. In addition to the symptoms of OM and its impact on quality of life and continued therapy, mucositis can cause adverse affects on a variety of other health and economic outcomes, such as a risk of serious infection, the need for parenteral nutrition and narcotic analgesia, and increased hospitalization and feeding-tube placement. The National Cancer Institute estimates that 400,000 patients in the U.S. suffer from OM during cancer therapy.

WHO OM Scale The WHO OM Scale is the standard, validated instrument used in clinical trials to measure OM.

Grade 0 = None Grade 1 = Erythema and soreness; No ulcers Grade 2 = Ulcers; Able to eat a solid diet Grade 3 = Ulcers; Requires a liquid diet Grade 4 = Ulcers; Not able to tolerate a solid or liquid diet; Requires IV or tube feeding.

About SCV-07 SCV-07 (gamma-D-glutamyl-L-tryptophan) is a small molecule which appears to stimulate the immune system through inhibition of STAT3 signaling and the resulting effects on T-helper 1 cells. SCV-07 has been shown to be efficacious in animal models of immune-sensitive diseases, including OM prevention, treatment of viral infections and cancers, and in the enhancement of response to vaccines.

Additionally, SciClone is currently running a multicenter, multidose, open label phase 2 clinical trial of SCV-07 as a monotherapy and in combination with ribavirin to treat patients infected with hepatitis C virus, who have relapsed after the last treatment. SCV-07 has shown a good safety profile in several early stage clinical trials in healthy volunteers and subjects with HCV infection at various doses. SciClone expects to provide initial results from this trial in the second half of 2010.

SCV-07 is protected by composition of matter patents as well as multiple method of treatment patents. SciClone has exclusive worldwide rights to SCV-07 outside of Russia, where the molecule has recently been approved for stimulation of depressed immune systems.

"TIV News" Tri-Valley Reports 9.8 Million Barrels of Oil Reserves at Year-End 2009
Source: Business Wire
Mar. 30, 2010

http://www.environmental-expert.com/resultEachPressRelease.aspx?cid=28518&codi=159627

BAKERSFIELD, Calif.--(BUSINESS WIRE)-- Tri-Valley Corporation (NYSE AMEX:TIV) announced today the company’s year-end 2009 oil reserves determined in accordance with the new Federal regulatory oil and gas disclosure rules. Tri-Valley’s total oil reserves at the end of 2009 were 9.8 million barrels compared to no reportable barrels of reserves at the end of 2008.

Tri-Valley’s 2009 year-end oil reserves included 3.0 million barrels of proved reserves, 0.8 million barrels of probable reserves and 6.0 million barrels of possible reserves. Tri-Valley’s ability to disclose improved oil reserves arises in part from new U.S. Securities and Exchange Commission (SEC) oil and gas disclosure rules effective January 1, 2010. The new SEC rules require a 12-month average oil price to be used to estimate future revenues, and, also permit the voluntary disclosure of probable and possible reserves.

At year-end 2008, the company had no reportable proved oil reserves as a consequence of the dramatic fall in world oil prices in the last two quarters of 2008 that negatively impacted the last sales price of the year used in the forecast of future revenues under the previous SEC disclosure rules.

The 2009 reserves disclosure also includes 6.8 million barrels of probable and possible reserves voluntarily reported by the company for the first time as now allowed under the new SEC rules. Most of the probable and possible reserves at year-end 2009 were related to Tri-Valley’s interest in its Pleasant Valley heavy oil project at the Oxnard Oil Field in Ventura County, California, which is in the early stages of development by the company.

Tri-Valley’s year-end 2009 reserves were estimated by independent reserves engineers in accordance with the new SEC oil and natural gas reserve disclosure rules. Under the rules, the company was required to use a 12-month arithmetic average of the sales price for the first day of each month to calculate future revenues. Tri-Valley’s voluntary reporting of probable and possible reserves under the new rules is intended to provide investors with more information about the company’s opportunities to potentially increase its proved reserves in the future. This view is shared by many in industry who provided supportive comments to the SEC during the public comment period on the new rules; and ultimately, the SEC agreed to allow voluntary reporting of probable and possible reserves when the final disclosure rules were published.

As the world economy witnesses early signs of economic growth from the deepest recession since the 1930’s, the company anticipates demand for energy will likewise rise again. Tri-Valley looks forward to further progress in capitalizing on its present, probable and future reserves to attain long term value for its shareholders as our economy shifts to a positive business cycle.

The following table describes Tri-Valley’s proved, probable and possible crude oil and natural gas reserves as of December 31, 2009, 2008 and 2007 (please note that 2008 and 2007 were calculated under the prior SEC rule):

Year Ending
BBL MCF
Crude Oil Natural Gas
December 31, 2009 Developed 282,271 395,252
Undeveloped 2,738,439 0
Net Proved 3,020,710 395,252

Probable 760,000 0
Possible 6,045,425 42,008
Net Prospective 6,805,425 42,008

December 31, 2008 Developed 0 695,931
Undeveloped 0 0
Net Proved 0 695,931

Probable 0 0
Possible 0 0
Net Prospective 0 0

December 31, 2007 Developed 372,048 791,128
Undeveloped 0 0
Net Proved 372,048 791,128

Probable 0 0
Possible 0 0
Net Prospective 0 0


About Tri-Valley

Tri-Valley Corporation explores for and produces oil and natural gas in California, and has two exploration-stage gold properties and a high grade calcium carbonate quarry in Alaska. Tri-Valley is incorporated in Delaware, and is publicly traded on the NYSE AMEX exchange under the symbol "TIV." Our company website, which includes all SEC filings, is www.tri-valleycorp.com.

"ENVK NEWS" Xemex Holdings Corp. Completes Merger With Envirokare Tech, Inc. and Announces Name Change and Reverse Stock Split

http://money.cnn.com/news/newsfeeds/articles/marketwire/0602430.htm

March 30, 2010: 02:39 PM ET

Envirokare Tech, Inc. (PINKSHEETS: ENVK) (the "Company"), announced that it has started the process to change its name to Xemex Group, Inc. to better reflect its new business model. Earlier this month, the Company acquired Xemex Holdings Corp. ("Xemex"), a commercial real estate management and development company headquartered in Brooklyn, New York.

The Company also announced that its Board of Directors has approved a 1 for 1,000 reverse split of the Company's common stock, thus reducing the outstanding common stock from 68,496,702 to approximately 68,496. Mr. Pappas, CEO, stated, "The reverse stock split of our common stock represents the next step in the Company's growth and development which will provide the foundation for access to the public capital markets."

Both the name change and the reverse stock split are subject to approval by FINRA and will take effect when approved by FINRA.

About "Xemex": Envirokare Tech, Inc., through its Xemex Holdings Corp. subsidiary, specializes in the management, development and co-op/condo conversions of residential, commercial and mixed use real estate projects. Xemex presently owns and operates a portfolio of residential and commercial properties in Brooklyn, New York. Management possesses significant experience in all real estate aspects such as management, construction, finance, rentals, leasing, co-op and or condo conversions and development (www.xemexgroup.com).

"CYPW News" Cyclone Power Technologies Delivers Biomass-to-Power System to Robotic Technology

http://www.marketwatch.com/story/cyclone-power-technologies-delivers-biomass-to-power-system-to-robotic-technology-2010-03-30?reflink=MW_news_stmp

POMPANO BEACH, Fla., Mar 30, 2010 (BUSINESS WIRE) -- Cyclone Power Technologies Inc. (Pink Sheets:CYPW) has successfully completed its biomass-to-power engine system for Robotic Technology Inc. (RTI) under its Statement of Work, and has delivered the renewable power system to the University of Maryland to be coupled with RTI's autonomous robotic platform.

Cyclone's prototype biomass-to-power generator is a self-contained, compact system that utilizes the company's award-winning waste heat engine (WHE) to produce power from plant-based biomass combustion. RTI is currently developing the Energetically Autonomous Tactical Robot (EATR), under a Phase II SBIR project sponsored by the Defense Advanced Research Projects Agency (DARPA), an agency of the U.S. Department of Defense. The EATR's ultimate mission includes long range military reconnaissance without the need for manual or conventional re-fueling.

"We are very pleased with the performance of Cyclone's biomass-to-power system, and now look forward to adding it to our intelligent robotic platform in completion of our Phase II contract award from DARPA," stated Dr. Robert Finklestein, President of RTI.

At the heart of Cyclone's current biomass-to-power system for the proof-of-concept EATR is the patent pending WHE, a six-cylinder Rankine cycle external heat engine capable of generating up to 18HP of mechanical power. An attached combustion chamber produces up to 600degF of steam to run the WHE at peak performance. An alternator then converts mechanical energy from the engine into as much as 10kW of usable electricity to power electronics or recharge batteries. A more powerful version of the WHE is expected to be used in future field prototypes of the EATR.

"This was a very meaningful and interesting project for Cyclone, in which we learned a great deal about our waste heat engine and the combustion of renewable vegetative biomass for its fuel source," stated Travis Love, Cyclone's Project Engineer for the WHE system. "We believe these lessons will serve us well as we continue along the path of commercializing our technology."

The robotic system being developed by RTI with Cyclone's portable biomass-to-power plant has numerous potential commercial applications outside military purposes, such as in border patrol, agriculture, forestry, natural disaster clean-up and recovery, and power generation in industrial or large-scale farming and logging settings. To view Cyclone's biomass-to-power engine system, visit: www.cyclonepower.com/video.html.

"CMGR News" Camelot Reels in 'Fink!' Distribution Division Acquires Sam Worthington Crime Action Film

http://www.marketwatch.com/story/camelot-reels-in-fink-2010-03-30?reflink=MW_news_stmp

LOS ANGELES, Mar 30, 2010 (GlobeNewswire via COMTEX) -- Camelot Entertainment Group, Inc. /quotes/comstock/11k!cmgr (CMGR 0.00, 0.00, 0.00%) ("Camelot") announced today that Camelot Distribution Group has acquired Fink!, a crime adventure about four fiercely outlandish hit men, three seasoned slackers, two idealist computer hackers, and an undercover cop whose paths all ironically cross when one of them screws over crime lord Terence Fink.

The cast includes Sam Worthington (Avatar, Terminator Salvation, Clash of the Titans), Steve Bastoni (Matrix Reloaded), Jonny Boxer, Jason Crewes (Neighbours), and Brett Stiller (Garage Days).

The film is written and directed by Tim Boyle and produced by Peter Taylor, Shaun Jefford, and Tim Boyle.

"We are very excited to have Fink! included in our lineup," stated Jamie Thompson, President of Camelot Distribution Group. "It's a humorous crime action film that is well produced and stars Avatar's Sam Worthington."

Fink! will premiere at MIPTV next month.

"IACH News" Information architects signs a definitive agreement with timerking

http://www.officialwire.com/main.php?action=posted_news&rid=120748

Architects Corp. (Pink Sheets: IACH) announced today that it has signed a definitive agreement with TimerKing and plans to close in early April 2010.

TimerKing an Energy Star Rated Product is the leader in energy efficient commercial and pizza oven timers. Timerking, Manufactures, Markets and Installs energy efficient Commercial and Pizza Oven Timers. Timerking products are qualified for the National Grid Utility Energy Efficiency Rebate Program. Currently, customers are receiving rebates of $1,000.00 for installing energy saving timers, along with lower monthly energy costs.

IAGreen along with TimerKing will begin to expand current and new products to Restaurants, Bakeries, Foundries. IAGreen will begin a national and global distribution of current and new products. TimerKing is currently considering franchising as a part of our future growth.

William Craig, ACEO, states TimerKing is a huge step for the company’s “Green” efficient goal. With the cost effective benefits that come along with TimerKing, there are also many Federal Grants available for this product that IACH will be able to take advantage of. This is a huge “Green” accomplishment that management has acquired. IACH evaluates countless opportunities daily; furthermore the company came up with the very best solution that can and will suit all of IACH’s needs.

Ms. Craig notes TimerKing is an immense component required to facilitate IACH to move forward into the “Green” industry. In today’s economy, energy efficiency is exceedingly imperative. This new technology of TimerKing will allow for the IACH to grow as a “Green” company. Even the richest companies are currently struggling to reinvent themselves in an effort to create viable, sustainable forward motion. It seems clear that a well structured small company with strong support from already vested stock holders and a trained eye for emerging technology could rapidly consolidate existing opportunities into real value. As noted before, Information Architects is positioned to be a profitable part of the "Change Wave" that is already upon us all.

"SPOF News" SPOOFEM.COM Approved to Receive Government Contracts

http://www.marketwire.com/press-release/SPOOFEMCOM-Approved-to-Receive-Government-Contracts-1139844.htm

ATLANTA, GA--(Marketwire - March 30, 2010) - SPOOFEM.COM (PINKSHEETS: SPOF) today announced their enrollment in and approval by both the Central Contractor Registry (CCR) and Online Representation and Certification Application (ORCA). SPOOFEM.COM has listed all certifications, representation and abilities on the ORCA which expands the company's ability for a broader market of contracts. Enrollment into these programs entitles SPOOFEM.COM to begin to apply for and receive government contracts that range from $25,000 well into the multimillion dollar range.

"Our acceptance by the CCR and the ORCA is very important for SPOOFEM.COM," says Kendric Embree, Business Development. "With our enrollment, we will be able to reach a broader market for potential buyers that will increase our corporate income."

The CCR is the primary registrant database for the U.S. Federal Government. CCR collects, validates, stores and disseminates data in support of agency acquisition missions. The ORCA is an e-Government initiative that was designed by the Integrated Acquisition Environment (IAE) to replace the paper based Representation and Certifications process. The ORCA works collaboratively with the CCR to simplify the governmental contract process.

"SPOOFEM.COM offers a wide variety of useful applications that can be used by not only consumers but also federal and governmental organizations and agencies. Our acceptance, will allow SPOOFEM.COM to remain a top competitor with the investigative and commercial industry," says Embree.

"EHYD News" eHydrogen Solutions Announces New Self-Contained Hydrogen Cell Requiring No Outside Power Source

http://money.cnn.com/news/newsfeeds/articles/marketwire/0601950.htm

March 30, 2010: 09:00 AM ET

(PINKSHEETS: EHYD) eHydrogen Solutions, Inc. (eHs) announced an important addition to its core On Demand Hydrogen Production capabilities with the launch of the H2-Reactor Development Project. The H2-Reactor is a self contained On Demand Hydrogen Production (ODHP) system utilizing only water and reactive metal alloys including aluminum or magnesium. No outside power source is required and the system generates no emissions. The resultant oxides and alloys are economically replenished, sustainable, and recyclable.

The reactive metals cause water molecules to release hydrogen and oxygen, which immediately reacts with aluminum to produce aluminum oxide (alumina) which can be recycled back into aluminum. Recycling aluminum from nearly pure alumina is less expensive than mining the aluminum-containing ore bauxite, thereby creating a reusable, sustainable, and zero-emission power source.

By recycling aluminum oxide back to aluminum, the cost of producing energy both as hydrogen and heat will continually decrease, and is expected to be well below 10 cents per kilowatt hour.

The Company views the H2-Reactor addition an essential addition to its overall design vision for its core ODHP technologies, particularly for high volume real-time hydrogen production environments such as Industrial Heating and Power Generation.

The Company recently announced the integration of its H-Solaris technology development, utilizing solar energy as the main power source for real-time hydrogen creation direct from water, with its expanding US Home Heating Joint Development Project. This addition of H2-Reactor capabilities not only adds further ODHP options for the expanding residential Combined Heating and Power market, but opens up the expansive Industrial Heating and Power Generation Market.

The H-Solaris and H2-Reactor development projects, together with the Company's advanced electrolysis technologies, when integrated into a fuel cell, hydrogen powered generator and/or advanced battery storage, enable sufficient hydrogen production to power a wide variety of residential, commercial and industrial applications. This has important potential implications, since hydrogen can be economically produced on-site and does not need to be transported.

The Company believes Distributed Power Generation, particularly Combined Heating and Power, to be an emerging growth sector promising to become a significant and vital energy option primed for strong sales growth.

The Company intends to develop and license a variety of technologies and power systems founded on its core holdings. The Company will make further announcements on the progress of each of these new initiatives and as the various core technologies are integrated into its development and partnership programs.

"PPTO News" Precision Petroleum Corporation- Finalizing Technical Analysis on Booch Sandstone, Seminole County, Oklahoma

http://www.marketwatch.com/story/precision-petroleum-corporation-finalizing-technical-analysis-on-booch-sandstone-seminole-county-oklahoma-2010-03-30?reflink=MW_news_stmp

OKLAHOMA CITY, OKLAHOMA, Mar 30, 2010 (MARKETWIRE via COMTEX) -- PRECISION PETROLEUM CORPORATION (Nevada Company), /quotes/comstock/11k!ppto (PPTO 0.08, +0.03, +66.67%) (the "Company") is pleased to announce that it is finalizing a technical analysis of the Booch Sandstone drilling prospect in Seminole County, Oklahoma.

Pending a positive result from this study, Precision intends to purchase a working interest in the current drilling program proposal from HoCo, Inc., the operator of the Booch Sandstone.

The prospected target, Tyler No. 1 is located in the northeast quarter of Section 33, T9N-R7E. This spud location is adjacent to the established Booch Sandstone well producing high gravity crude from the Sandstone at 3,500 feet.

A renewed vitality has been introduced for the completion methods adopted for this type of Sandstone geology. This innovation involves a pressurized injection with oil base fluids. This procedure has offered multiple areas of investigation and enhanced oil accumulations at a relative low developmental cost.

Porterfield further stated that a successful Tyler No. 1 will afford Precision an opportunity to participate in multiple Tyler offsets. The potential entry by Precision into this Booch Sandstone play will certainly compliment Precisions existing 18 producing leases in the various Oklahoma oil basins. Porterfield also mentions that these Tyler leases have access to all the necessary infrastructures for power, water, storage and delivery.

Precision Petroleum Corporation is an independent energy company engaged in the acquisition, exploration and development of oil and natural gas properties in North America. Precision's objective is to seek out and develop opportunities in the oil and natural gas sectors that represent a low risk opportunity. As well, Precision aims to define larger projects that can be developed with Joint Venture Partners. More information about the company is available at; www.precisionpetroleumcorp.com.

"HNAB News" Hana Biosciences Receives Notice of Allowance for Menadione Patent for the Prevention and Treatment of EGFR Inhibitor Cancer Therapy-Associated Rash

http://www.marketwatch.com/story/hana-biosciences-receives-notice-of-allowance-for-menadione-patent-for-the-prevention-and-treatment-of-egfr-inhibitor-cancer-therapy-associated-rash-2010-03-30?reflink=MW_news_stmp

SOUTH SAN FRANCISCO, Calif., Mar 30, 2010 (GlobeNewswire via COMTEX) -- Hana Biosciences /quotes/comstock/11k!hnab (HNAB 0.20, +0.01, +2.63%) , a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for the use of menadione to prevent and treat skin rash in patients taking biologic and small molecule epidermal growth factor receptor (EGFR) inhibitors, such as Erbitux(R) and Tarceva(R), for anti-cancer therapy. The U.S. Patent Application Number 11/886,803 is entitled "Vitamin K for Prevention and Treatment of Skin Rash Secondary to Anti-EGFR Therapy" and extends intellectual property protection around menadione into 2026. The Company also has a similar patent application for menadione co-pending in Australia, Canada, Europe, Hong Kong, Japan, and Korea. Additional applications extending the use of menadione have been filed.

"This Notice of Allowance reinforces our commitment to developing topical menadione as a first-in-class therapeutic targeted at the dose-limiting skin toxicities in patients taking EGFR inhibitors," said Steven R. Deitcher, M.D., President and Chief Executive Officer of Hana Biosciences. "The majority of patients taking EGFR inhibitors develop a skin rash, which leads to delay, reduction and even discontinuation of EGFR inhibitor therapy in a substantial percentage of patients. Currently, there are no approved treatments available."

Hana has completed a Phase 1 study of menadione topical lotion in healthy volunteers, which demonstrated delivery of menadione into the skin without appreciable systemic absorption. In addition, menadione topical lotion was generally well-tolerated. The Company has recently completed enrollment of a proof-of-concept study of menadione topical lotion in cancer patients receiving EGFR inhibitors for anti-cancer therapy. This study assessed both treatment potential in patients with new onset rash and prophylactic potential in those about to begin an EGFR inhibitor. The Company expects to present the proof-of-concept data and initiate a randomized Phase 2 trial by the end of 2010.

Rash is a common, painful and treatment-limiting skin toxicity side effect of all approved EGFR inhibitors (e.g. Tarceva(R), Iressa(R), Erbitux(R), Vectibix(R), Tykerb(R)) with incidence rates as high as 90 percent. EGFR inhibitor-associated rash can lead to reduced compliance and cause dose reductions, delays or discontinuation of EGFR inhibitor therapy in a significant portion of affected patients. Currently, there are no products or therapies FDA-approved to treat these skin toxicities.

"FNDM News" Fund.com Acquires Weston Capital Management

http://www.prnewswire.com/news-releases/fundcom-acquires-weston-capital-management-89501157.html

Fund.com Expands its Operations to Include Originating, Developing and Distributing Hedge Funds and Actively Managed ETFs

NEW YORK, March 30 /PRNewswire-FirstCall/ -- Fund.com, Inc., (OTC Bulletin Board: FNDM) announced here today that effective as of March 29, 2010, it has acquired Weston Capital Management, LLC, an originator and distributor of hedge funds.

Founded in 1993 and headquartered in West Palm Beach, FL., Weston Capital earns fees on assets exceeding $1.0 billion under management. It has three lines of business: it originates and markets fund of funds; it originates and markets single-manager hedge funds; and it raises capital to seed new hedge funds. In 2010, Weston Capital and Harcourt AG formed a strategic alliance for investment manager identification and fund seeding. Harcourt, a $4.5 billion alternative investments manager that is majority owned by Vontobel Group, the $70 billion Swiss banking group, is a leading global advisor of alternative investments for institutional investors.

Weston Capital founder Albert Hallac continues as CEO of Weston Capital, directing its day-to-day operations and business strategy. In addition, Fund.com Chairman Joseph J. Bianco will become Chairman of Weston Capital. Weston Capital also has offices in London and New York City.

Fund.com CEO Gregory Webster and Weston Capital CEO Albert Hallac said, "We believe with the Weston Capital operations when aligned with Fund.com's majority interest in AdvisorShares, a developer and marketer of actively managed ETFs, Fund.com will be able to significantly accelerate increases of assets under management since it now has the ability to seed, originate and distribute hedge funds as well as seed, originate, develop and distribute actively traded ETFs to institutional and retail investors. AdvisorShares, Bethesda, MD, is one of the few companies that has been able to obtain approval from the US Securities and Exchange Commission to create actively managed ETFs. The ETF sector has assets more than $1 trillion and is the fastest growing segment of the fund management industry."

Webster added, "With Weston Capital's proven capability to seed new fund products, combined with its seasoned global institutional sales force, Fund.com is now positioned to capture revenue streams from an array of hedge fund and actively managed ETFs. Importantly, Weston has the global institutional relationships that can capitalize on AdvisorShares patent-pending exchange-traded fund platform as well as powerful distribution capability among institutions worldwide."

AdvisorShares CEO Noah Hamman said, "Weston and AdvisorShares are perfectly complementary and we are looking forward to working with Weston to originate ETFs as well as help other managers launch their own ETFs and to market our actively managed ETFs to institutions worldwide with the expertise of Weston Capital's established sales force. These activities will greatly expand our footprint in the rapidly growing market of actively traded ETFs."

Hallac said, "Weston anticipates that with greater resources and an entry to the fast-growing ETF market, we will offer our existing and potential clients a broader range of financial investment opportunities. In particular, we see great potential for growing our assets under management and related fee income by expanding our seeding platform to include the origination and development of new actively managed ETFs."

Under the Harcourt strategic alliance, Weston Capital and Harcourt will seed and develop new hedge fund businesses via Weston Capital's incubation platform. The alliance combines Weston's extensive experience in early stage hedge fund investing and marketing with Harcourt's proven investment expertise in global manager selection, due diligence and risk management.

Since January 2004, Weston Capital's hedge fund seeding platform (via the Weston-Atlas Partners Fund and the Weston Capital Partners Fund II) has provided sponsor capital for 13 emerging hedge fund managers. Weston intends to raise $250 million for its third incubation fund, Partners III, which will seed both hedge funds and actively managed ETFs, with Harcourt providing investment infrastructure and risk management.

"UDHI News" Union Dental to Be Profitable for Year Ending 2009
http://money.cnn.com/news/newsfeeds/articles/marketwire/0598090.htm
March 30, 2010: 07:30 AM ET

Union Dental Holdings, Inc. (PINKSHEETS: UDHI) -- http://www.uniondental.com/ir -- a Company that operates and manages a network of dentists throughout the United States for union members announced today it anticipates being profitable in the year ending 12/31/2009 with revenues in excess of $3,000,000. This will be the eighth straight quarter the company has reported profits.

Dr. George D. Green, President & CEO commented: "Although the financial process is not completed we are pleased to report that we will be profitable for the year end 12/31/09. It has taken a lot of hard work by all of our staff members to stay in profitability. It is even more gratifying that we have done this during the most downward economic spiral since the great depression."

"ONCY News" Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 SCC Lung Cancer Trial

http://www.prnewswire.com/news-releases/oncolytics-biotechr-inc-announces-start-of-enrolment-in-us-phase-2-scc-lung-cancer-trial-89499807.html

CALGARY, March 30 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the Cancer Therapy & Research Center at the University of Texas Health Science Center (CTRC) has started patient enrolment in a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with carboplatin and paclitaxel in patients with squamous cell carcinoma of the lungs (SCC lung cancer). The Principal Investigator is Dr. Alain C. Mita of the CTRC.

"There are significant similarities between SCC lung and SCC head and neck cancers," said Dr. Karl Mettinger, Chief Medical Officer for Oncolytics. "We are observing clinical benefit in a majority of our SCC head and neck cancer patients treated to date. We have seen clinical responses in metastatic lung lesions with REOLYSIN whether used as a monotherapy or in combination with paclitaxel and carboplatin, and are hopeful that this treatment combination will provide similar benefit to SCC lung cancer patients."

"This clinical study expands our interests into a variety of lung cancers," said Dr. Matt Coffey, COO for Oncolytics. "In addition to this study, we are enrolling patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumors in a U.S. Phase 2 clinical trial using REOLYSIN in combination with paclitaxel and carboplatin."

"The study offers new hope for this group of patients with lung cancer," said principal investigator Alain C. Mita, M.D., a medical oncologist and assistant professor of medicine at the CTRC at the UT Health Science Center.

The trial (REO 021) is a single arm, open-label, Phase 2 study of REOLYSIN given intravenously with paclitaxel and carboplatin every three weeks. Up to 55 patients are expected to be treated in this trial.

Eligible patients include those with metastatic stage IIIB, or stage IV, or recurrent squamous cell carcinoma of the lung who are chemotherapy naïve for their metastatic or recurrent cancer.

The primary objective of the Phase 2 trial is to assess the antitumor effect of the treatment regimen in the study population in terms of objective response rates. The secondary objectives are to assess progression-free survival and overall survival for the treatment regimen in the study population; to determine the proportion of patients receiving the above treatment who are alive and free of disease progression at six months; and to assess the safety and tolerability of the treatment regimen in the study population.

This trial is part of a broad preclinical and clinical collaboration with the CTRC that will involve up to five, open-label, Phase 2 studies exploring the use of REOLYSIN in combination with chemotherapy for various cancer indications.

"ENZ News" Enzo Biochem Says Favorable Patent Appeals Court Decision Will Allow Pursuit of Claim for Substantial Damages

http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18722

Enzo Biochem Inc. (NYSE:ENZ) said today that a decision released Friday by the Court of Appeals for the Federal Circuit reversing a district court’s summary judgment will enable the Company to pursue a claim for substantial damages against Applera Corporation, now Life Technologies Corporation. (NASDAQ: LIFE). The Court of Appeals vacated the lower court’s judgments of invalidity on United States Patent Nos. 5,328,824 and 5,449,767.

The asserted patents cover pioneering technologies relating to compounds used in DNA sequencing systems to read the genetic code. The complaint against Applera Corporation and its subsidiary Tropix Inc. charged patent infringement arising out of the misappropriation of Enzo’s proprietary and pioneering patented technologies related to DNA sequencing systems, and other products, as well as providing others with unauthorized and prohibited access to the patented products and technologies.

“The Appellate Court’s ruling clears the way for us to pursue claims related to the broad scope of the products subject to our patents, and substantially weakens the defense of Applera with respect to their potential liability,” said Elazar Rabbani, PhD, Enzo Chairman and CEO. “This decision allows us to seek redress in terms of claims for damages. When the Federal Circuit mandate issues in about three weeks, remanding the case to the District Court in New Haven, Connecticut, and assuming Applera does not seek rehearing or reconsideration, we will be able to promptly move forward with our case.”

Additionally, the Court of Appeals affirmed the lower court’s ruling that a construction of U.S. Patent No. 5,082,930 was not infringed and that U.S. Patent No. 5,476,918 was invalid. These rulings will not affect Enzo’s claims against Applera, since Enzo believes that Applera’s products are covered by US Patents 5,328,824 and/or 5,449,767.

About Enzo Biochem

Read more: http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=18722#ixzz0jew1zv3N

"CNLG NEWS" Conolog Announced Today That It Has Filed a Patent Application for Its "GlowWorm" Fiber Optic Detector
Specific Product for Any Fiber Optic Network or Line

http://www.marketwatch.com/story/conolog-announced-today-that-it-has-filed-a-patent-application-for-its-glowworm-fiber-optic-detector-2010-03-29?reflink=MW_news_stmp

SOMERVILLE, N.J., Mar 29, 2010 (BUSINESS WIRE) -- Conolog Corporation /quotes/comstock/15*!cnlg/quotes/nls/cnlg (CNLG 1.66, +0.02, +1.22%) , an engineering and design company that provides digital signal processing solutions to global electric utilities, announced today that it has filed a patent application with the U.S. Patent and Trademark Office for its "GlowWorm" fiber optic detector.

President of Conolog Marc Benou stated, "Our "GlowWorm" detector, which completed field testing in February, surpassed our expectations and demonstrated its capability to handle more than just utility applications."

This application of passive detection and its associated command technology is unique to Conolog and will allow utilities and other customers to quickly determine the source of a fiber optic signal failure."

Benou concluded, "Conolog products continue to demonstrate the global applications of our products, ease of installation and our commitment to low maintenance and long term security and reliability. The introduction of the GlowWorm detector will hopefully lead to a new family of products for Conolog."

"JOEZ News" Joe's Jeans Enters Into $5.5 Million Agreement to License Footwear
March 30, 2010: 06:00 AM ET
http://money.cnn.com/news/newsfeeds/articles/marketwire/0602174.htm

Joe's Jeans Inc. (the "Company") (NASDAQ: JOEZ) announced today that it has signed a new license agreement with Burano LLC to manufacture and distribute Joe's® branded footwear for women. The initial term of the agreement is for three years with minimum net sales commitments of $5.5 million over the term.

The new line of women's shoes represents a stylish complement to an ever-expanding Joe's® wardrobe. The first shipment consists of ballet flats in a variety of embellishments and textures and began shipping this month to major department and specialty store retailers, Company owned retail stores and its Internet store with a retail price of $120 to $145. The ballet flats are intended to be offered every season with a new interpretation on the classic shoe. In April, a line of wedges, flat sandals and casual heels is expected to begin shipping and the Fall line, including boots, is expected to begin shipping in July. The shoes will have a vintage look with a feminine vibe and sexy attitude. The offerings will include soft, draping leathers in rich colors and a focus on intricate detailing on the soles.

"We believe our new line of Joe's® branded footwear will contribute to continued brand name recognition and overall growth for 2010. The shoe line will reflect and embody the Joe's® customer, as a fashion forward, casual woman with an independent streak," said Marc Crossman, President and Chief Executive Officer. Crossman continued, "We are excited to be able to offer our customer fashion forward shoes at attractive retail price points and look forward to the line's development in our collection."

"AMIN News" American International Industries, Inc. Announces the Completion of the Reverse Merger of Its Subsidiary, Delta Seaboard Well Service, Inc. Into Hammonds Industries, Inc.

http://www.marketwatch.com/story/american-international-industries-inc-announces-the-completion-of-the-reverse-merger-of-its-subsidiary-delta-seaboard-well-service-inc-into-hammonds-industries-inc-2010-03-30?reflink=MW_news_stmp

HOUSTON and KEMAH, Texas, Mar 30, 2010 (GlobeNewswire via COMTEX) -- Mr. Daniel Dror, Chairman and CEO of American International Industries, Inc. /quotes/comstock/15*!amin/quotes/nls/amin (AMIN 1.06, 0.00, 0.00%) , today announced that its subsidiary, Delta Seaboard Well Service, Inc. ("Delta"), has completed its reverse merger with Hammonds Industries, Inc. (Pink Sheets:HMDI), as a result of which Delta has become a wholly-owned subsidiary of Hammonds. In connection with the transaction, Hammonds' name will be changed to Delta Seaboard International, Inc.

The Company has prepared all documentation for submission to FINRA necessary to implement the name change and the 1:10 reverse split. Upon the effective date of the name change and the reverse split, Delta will be issued a new trading symbol. In addition, Delta is working with a market maker to prepare and file a Form 211 pursuant to SEC Rule 15c2-11 to become eligible for quotation on the OTCBB.

American International Industries, Inc. is a diversified holding company, with a business model similar to General Electric, Tyco International, and Berkshire Hathaway. The Company has holdings in Industry, Finance, and Real Estate in Houston, Texas and surrounding areas, and Oil & Gas. The vision of the Company is to develop holdings in various industries through acquisition of existing companies, applying the financial resources and management expertise to foster the growth and profitability of the acquired businesses. The holding company serves as a financial and professional partner to the management of the subsidiaries. The role of the holding company is to improve each subsidiary's access to capital, achieve economies of scale by consolidating administrative functions, and utilize the financial and management expertise of corporate personnel across all units. The Company is continuing to work with management of the subsidiary companies to improve revenues, operations and profitability.

Delta Seaboard Well Service, Inc. is an onshore rig-based well-servicing contracting company providing services to the oil and gas industry.

"HMDI News" American International Industries, Inc. Announces the Completion of the Reverse Merger of Its Subsidiary, Delta Seaboard Well Service, Inc. Into Hammonds Industries, Inc.

http://www.marketwatch.com/story/american-international-industries-inc-announces-the-completion-of-the-reverse-merger-of-its-subsidiary-delta-seaboard-well-service-inc-into-hammonds-industries-inc-2010-03-30?reflink=MW_news_stmp

HOUSTON and KEMAH, Texas, Mar 30, 2010 (GlobeNewswire via COMTEX) -- Mr. Daniel Dror, Chairman and CEO of American International Industries, Inc. /quotes/comstock/15*!amin/quotes/nls/amin (AMIN 1.06, 0.00, 0.00%) , today announced that its subsidiary, Delta Seaboard Well Service, Inc. ("Delta"), has completed its reverse merger with Hammonds Industries, Inc. (Pink Sheets:HMDI), as a result of which Delta has become a wholly-owned subsidiary of Hammonds. In connection with the transaction, Hammonds' name will be changed to Delta Seaboard International, Inc.

The Company has prepared all documentation for submission to FINRA necessary to implement the name change and the 1:10 reverse split. Upon the effective date of the name change and the reverse split, Delta will be issued a new trading symbol. In addition, Delta is working with a market maker to prepare and file a Form 211 pursuant to SEC Rule 15c2-11 to become eligible for quotation on the OTCBB.

American International Industries, Inc. is a diversified holding company, with a business model similar to General Electric, Tyco International, and Berkshire Hathaway. The Company has holdings in Industry, Finance, and Real Estate in Houston, Texas and surrounding areas, and Oil & Gas. The vision of the Company is to develop holdings in various industries through acquisition of existing companies, applying the financial resources and management expertise to foster the growth and profitability of the acquired businesses. The holding company serves as a financial and professional partner to the management of the subsidiaries. The role of the holding company is to improve each subsidiary's access to capital, achieve economies of scale by consolidating administrative functions, and utilize the financial and management expertise of corporate personnel across all units. The Company is continuing to work with management of the subsidiary companies to improve revenues, operations and profitability.

Delta Seaboard Well Service, Inc. is an onshore rig-based well-servicing contracting company providing services to the oil and gas industry.

"WYNX News" CUI, Inc., a Subsidiary of Waytronx, Inc., Announces Advanced Power Topology License Agreement with California Power Research

http://www.marketwatch.com/story/cui-inc-a-subsidiary-of-waytronx-inc-announces-advanced-power-topology-license-agreement-with-california-power-research-2010-03-30?reflink=MW_news_stmp

TUALATIN, Ore., Mar 30, 2010 (BUSINESS WIRE) -- CUI, Inc., a subsidiary of Waytronx, Inc. /quotes/comstock/11k!wynx (WYNX 0.13, -0.01, -7.14%) , has entered into an exclusive Field of Use Agreement with California Power Research Inc to license their BPS-5 advanced power topology. BPS-5 provides advantages across a wide range of ac-dc and dc-dc power conversion applications through a significant reduction in switching losses within PWM circuits. This switching loss reduction translates to a potential for improved energy efficiency, faster transient response and increased power density when compared to the leading designs currently on the market.

"We are pleased to license our BPS-5 technology to CUI, Inc.," said Fred Barthold, Vice President of Engineering at California Power Research. "We feel this technology aligns well with CUI's recent entrance into the digital power market and their commitment to bringing advanced power solutions to their expanding customer base," explained Barthold.

Through its power product line, V-Infinity, CUI manufactures a range of embedded and external power electronics devices for OEM manufacturers.

Waytronx's President & CEO, William Clough, said, "We are very excited to partner with California Power Research to incorporate their BPS-5 technology into our line of products. Our team has developed a road map based on this technology that we feel will take full advantage of its benefits. This partnership continues our mission to bring the latest advances in power technology to market."

"This relationship continues to demonstrate our commitment to partner with 'best-of-breed,' world-class companies in order to acquire, develop, and commercialize leading-edge technology," Clough concluded.

"GOVX News" GeoVax Labs Granted Allowance By FDA to Start Phase 1 Clinical Trial For HIV/AIDS Therapeutic Vaccine

http://www.prnewswire.com/news-releases/geovax-labs-granted-allowance-by-fda-to-start-phase-1-clinical-trial-for-hivaids-therapeutic-vaccine-89498812.html
Company Will Begin Non-Blinded Study in HIV Infected Individuals Who Started Drug Treatment During Their First Year of Infection

SMYRNA, Ga., March 30 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, is now allowed by the FDA (US Food and Drug Administration) to begin a phase 1 clinical trial for GeoVax's therapeutic vaccine, which is intended as a treatment for individuals infected with HIV (Human Immunodeficiency Virus). The company will begin a non-blinded study in HIV infected individuals who started drug treatment during their first year of infection.

Robert McNally, Ph.D., President and CEO of GeoVax, stated, "Based upon preclinical animal data, we believe our therapeutic vaccine may improve treatment options for people infected with HIV and are delighted we will be able to begin a phase 1 clinical trial. An unmet need exists in the market for a HIV therapeutic vaccine if it can reduce the need for expensive and poorly tolerated lifelong oral medications currently available to infected individuals. We also recognize that this trial will enable GeoVax to gather crucial information toward our vaccine's success on a more timely basis than the time required to perform a preventative trial."

The protocol for the Phase 1 clinical trial, conceived in collaboration with ARCA (AIDS Research Consortium of Atlanta), will carefully monitor safety while evaluating the ability of the vaccine to elicit protective immune responses in vaccinated participants. The next step of starting the process will be a submission by ARCA to the IRB (Institutional Review Board) for local review of trial documentation, a standard requirement to protect human subjects. The trial is based on the achievement of post-vaccine viral control in animal studies conducted in recently infected non-human primates at the Yerkes National Primate Research Center, affiliated with Emory University.

"TDEY News" 3D Eye Solutions, Inc. Begins Beta Testing for Glasses Free 3D Applications for the Nintendo Wii and Apple iPhone Video Game Platforms

http://www.prnewswire.com/news-releases/3d-eye-solutions-inc-begins-beta-testing-for-glasses-free-3d-applications-for-the-nintendo-wii-and-apple-iphone-video-game-platforms-89107292.html

LONGWOOD, Fla., March 25 /PRNewswire-FirstCall/ -- 3D Eye Solutions, Inc. (OTC Pink Sheets: TDEY) is pleased to announce that the Company has begun beta testing for its glasses free 3D application for the video game platforms such as, Nintendo® Wii, Apple® iPhone, Macintosh, and PC. 3D Eye Solutions is developing a new render engine that is more flexible in design and can be integrated with multiple gaming systems. 3D Eye Solutions new render engine fills a need in the $46.5 Billion video game industry as video game manufacturers release 3D ready hand held and console systems. According to an article in Bloomberg Business Week yesterday, Nintendo® announced that "it will sell a 3-D version of its DS handheld player that doesn't require the user to wear glasses. Nintendo, who's DS handheld sold more than 125 million units worldwide since December 2004, plans to disclose details of the new model at the E3 show in Los Angeles on June 15. The device will go on sale in the fiscal year starting April 1."

3D Eye Solutions has already started beta testing of its glasses free 3D application for the Nintendo® DS, Microsoft® Xbox, and the Sony® PlayStation® and expects its Beta Test to be completed by the end of the third quarter. The application is based on a server and new file format that will enable state synchronization of player appliances and the server. The application is developed mainly for use on glasses free systems, however, it is also compatible with 3D video game systems with glasses. In addition, this application will enable 3D Eye Solutions to be able to convert in "real time" across multiple platforms including cinema and television.

"We believe the future of 3D is coming to all markets and at a fast pace. We feel our new render engine will fulfill the gaps in the industry as it was developed around our conversion processing and delivery of content in a compelling way. Our dedication and development plans in the video game arena are in tune with the industry and we are excited to be a part of this revolution," stated Michael Gibilisco, CEO of 3D Eye Solutions, Inc.

"VGPR News" Vega's Georgia Manufacturing Plant to Produce Bio-Coal for European Power Companies

http://www.marketwatch.com/story/vegas-georgia-manufacturing-plant-to-produce-bio-coal-for-european-power-companies-2010-03-25?reflink=MW_news_stmp

LONDON, Mar 25, 2010 (MARKETWIRE via COMTEX) -- Vega Promotional Systems, Inc. (PINKSHEETS: VGPR) confirmed today that its Georgia manufacturing plant will produce bio-coal.

When completed, the manufacturing plant will use special torrefaction technology to produce bio-coal briquettes from organic waste products that will then be sold through agreements with European power generating companies.

The Company recently announced it has entered into an agreement with Austrian-based ECEM Salzburg Energy and Environment Consulting GmbH to sell 100% of the bio-coal produced at the Company's Georgia facility. ECEM will resell the product to power companies throughout Europe. The five year deal will generate approximately $17 million in annual revenue to Vega.

"Our original plan for the Georgia plant was to produce fuel pellets using existing technology," stated Vega Chairman, Michael K. Molen. "However, after extensive research with equipment manufacturers, industry experts, and potential clients around the world, we've determined that it would be more beneficial to use the torrefaction technology to produce bio-coal. Shipping is a large part of our business and significantly affects the price we can charge. Bio-coal will be much cheaper to ship to our clients than fuel pellets. Target markets for our products are power plants that face mandates to increase biomass usage in their coal burning plants. Firing the Company's bio-coal in existing coal plants will not require any retrofitting of existing power plants."

Torrefaction is a partial carbonization process that takes place at temperatures between 475 - 575 degrees in a low temperature environment which makes the physical and energetic properties of the biomass much more comparable to traditional coal. The biomass is then compressed into briquettes to be sold to the end user. Torrefaction has the added benefit of reducing or eliminating undesirable volatiles, such as nitrous oxides and sulfur dioxides and is considered carbon neutral to the environment.

By accounting for the positive environmental impact of not allowing biomass to decay and providing a positive impact through renewable energy under an approved methodology from the Clean Development Mechanism (CDM) under the United Nations Framework Convention on Climate Change (UNFCCC), the production and sale of carbon credits from the burning of biomass for CO2 production will guarantee additional income to Vega.

"IGNT News" Ingen Moves Forward to $84.4B Government Healthcare Market Investors Expected to See Huge Potential Going Forward

http://www.globenewswire.com/newsroom/news.html?d=187385

YUCAIPA, Calif., March 25, 2010 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), the leading manufacturer of in-line oxygen flow meters for respiratory medical devices, which helps companies similar to McKesson Corporation (MCK) and Amedisys Inc. (AMED) achieve substantial cost-savings by reducing support costs for in-home oxygen patients, recently announced that the company is set to expand into government and export markets.

Ingen, which has developed and patented an innovative "smart" cannula that monitors oxygen flow, stands at a key reflex point in generating shareholder value. Their flagship product has recently attained ISO certification which enables it to be sold internationally. The company has also applied for a key GSA certification to distribute the new Smart Nasal Cannula under various government contracts.

Ingen recently announced that they completed their ISO certification, which allows them to sell their products around the world. Even before this certification, the company had a significant backlog of international orders, which clearly demonstrate interest in their products abroad.

With COPD being the leading cause of death in Europe and Asia, the company expects to see significant demand for their patented Oxyview technology. In fact, some 200,000 to 300,000 people die each year in Europe from COPD, which amounts to 4.1% of men and 2.4% of women.

Ingen expects to meet their 2010 annual $11 million sales projection, with new distribution partners in Israel, as well as across Europe, Asia, Canada and Australia. Through these channels, the company anticipates to quickly ramp up sales around the globe.

With approximately 23.2 million military veterans in the United States and $84.4 billion federal dollars spent on veteran benefits programs alone, Ingen's GSA application will give the company access to a growing government market for healthcare products and services from the private sector. The government healthcare programs have an emphasis on new products that would result in any cost savings.

According to a 2004 report "COPD in VA Hospitals" by Jesse Roman and Rafael Perez, the U.S. government maintains one of the largest home oxygen delivery programs in the nation, serving some 23,000 patients with severe COPD, and costing upwards of $26 million per year.

In fact, COPD affects 16% of all VA hospital admissions and about a third of all admissions to VA medical services, according to the same report. This has led to the VA looking for new tools to improve quality of life, control costs, and provide caregiver satisfaction.

Ingen's innovative SMART nasal cannulas help reduce malpractice claims and unnecessary and costly in-home patient visits by providing patients with a real-time gauge of oxygen flow. With the company's application under review, it is easy to see that they stand at the forefront of a very large near-term market, ready for their products.

As more and more customers discover the benefits of this new smart nasal cannula with Oxyview technology, investors may see huge potential going forward.

"PBTH News" PROLOR Biotech Announces NYSE AMEX Listing Trading on NYSE AMEX Begins Monday, March 29, 2010 under Symbol "PBTH" -
March 25, 2010: 08:00 AM ET

http://money.cnn.com/news/newsfeeds/articles/prnewswire/NY76304.htm

NES-ZIONA, Israel, March 25 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH), a company developing next generation biobetter therapeutic proteins, today announced that it has been authorized to list its shares of common stock on the NYSE AMEX stock exchange. The company anticipates that its common stock will begin trading on the NYSE AMEX on Monday, March 29, 2010, under the trading symbol "PBTH." Until that time, PROLOR's common stock will continue to trade on the OTC Bulletin Board under the trading symbol "PBTH."

"We are pleased to be moving the listing of our common stock from the OTCBB to the NYSE AMEX," said Shai Novik, President of PROLOR. "This is an important milestone that we anticipate will raise PROLOR's profile in the global investor community and permit a larger number of institutional funds to consider adding PROLOR to their investable universe. Listing on the NYSE AMEX marks an important step in our ongoing efforts to improve the liquidity of our common stock while we continue to execute our growth strategy."

"We welcome PROLOR Biotech to the NYSE Euronext family of listed companies and to NYSE AMEX," said Scott Cutler, NYSE Euronext Executive Vice President and Head of Listings, Americas. "PROLOR Biotech and its stockholders will benefit from our superior market quality and technology, a broad array of issuer and investor services, and a global brand association. We look forward to building a strong and lasting partnership with the company and its stockholders."

Earlier this year, PROLOR reported results from a Phase I clinical study of its biobetter form of human growth hormone (hGH) that demonstrated its potential to reduce the required dosing frequency from one injection per day as required for currently available hGH to as few as two injections per month. Last week, PROLOR announced that it had closed a $24.4 million private placement of its common stock.

"AVTC News" AVT, Inc. Says It Meets Congressional Requirements on Calorie Counts

http://www.marketwatch.com/story/avt-inc-says-it-meets-congressional-requirements-on-calorie-counts-2010-03-25?reflink=MW_news_stmp

CORONA, Calif., March 25, 2010 /PRNewswire via COMTEX/ -- AVT, Inc. (formerly Automated Vending Technologies), (Pink Sheets: AVTC) today said it is already in compliance with new requirements in the recently passed major Health Care Reform Legislation that require vending machines to include calorie count information. The information will be available so consumers can view it before making their selections.

"For more than five years, our state-of-the-art dispensing machines integrated with high resolution LCD displays have had the ability to display nutritional information as well as streaming ads that can advise consumers of whatever information the law requires," said Shannon Illingworth, Company founder. "We are delighted to be ahead of the sector in this important matter and will be exhibiting this capability during the 2010 National Automatic Merchandising Association show (NAMA) in April at the McCormick Place West Chicago, Ill."

News publications, including The New York Times, The Wall Street Journal, The Boston Globe and The Associated Press, today reported on the provision in the health care reform legislation which previously had received little publicity. It also mandates that more than 200,000 fast food and other chain restaurants must post calorie information. The Food and Drug Administration is directed to create the new national standards within one year.

"Investors and possible clients should visit our web site at (www.avtinconline.com) to learn how we are in front of Congress in this matter," Mr. Illingworth said. AVT is noted for having developed significant technologies in the dispensing machine sector, including cashless payment, credit and debit card use, and dynamic advertising with remote tracking and inventory management, yielding more efficient and reliable vending systems.